News
ILMN
142.24
-2.69%
-3.93
Illumina (ILMN) Receives a Buy from Citi
TipRanks · 20h ago
Should SPDR Portfolio S&P 400 Mid Cap ETF (SPMD) Be on Your Investing Radar?
NASDAQ · 20h ago
Short + Long Strategies And What Alpha's Really All About
Seeking Alpha · 1d ago
Illumina coverage resumed at equal weight by Morgan Stanley
Seeking Alpha · 2d ago
ARKK's holdings ranked by SA Quant Grades
Seeking Alpha · 2d ago
ILLUMINA INC <ILMN.O>: MORGAN STANLEY RESUMES COVERAGE WITH EQUAL-WEIGHT RATING; PRICE TARGET $156
Reuters · 2d ago
Nvidia initiated, Airbnb downgraded: Wall Street’s top analyst calls
TipRanks · 2d ago
Illumina Price Target Announced at $156.00/Share by Morgan Stanley
Dow Jones · 2d ago
Morgan Stanley Reinstates Equal-Weight on Illumina, Announces $156 Price Target
Benzinga · 2d ago
Illumina Price Target Raised to $184.00/Share From $170.00 by Stephens & Co.
Dow Jones · 2d ago
Illumina Is Maintained at Overweight by Stephens & Co.
Dow Jones · 2d ago
Stephens & Co. Maintains Overweight on Illumina, Raises Price Target to $184
Benzinga · 2d ago
Illumina resumed with an Equal Weight at Morgan Stanley
TipRanks · 2d ago
Illumina price target raised to $184 from $170 at Stephens
TipRanks · 2d ago
ILLUMINA INC <ILMN.O>: STEPHENS RAISES TARGET PRICE TO $184 FROM $170
Reuters · 2d ago
Should Vanguard S&P Mid-Cap 400 Value ETF (IVOV) Be on Your Investing Radar?
NASDAQ · 2d ago
Illumina’s Hold Rating: Navigating Growth Uncertainty Amid Market and Geopolitical Challenges
TipRanks · 2d ago
U.S. RESEARCH ROUNDUP-Cable One, Neurogene, Topbuild
Reuters · 3d ago
Illumina Price Target Cut to $185.00/Share From $195.00 by Piper Sandler
Dow Jones · 3d ago
Illumina Is Maintained at Overweight by Piper Sandler
Dow Jones · 3d ago
More
Webull provides a variety of real-time ILMN stock news. You can receive the latest news about Illumina Inc through multiple platforms. This information may help you make smarter investment decisions.
About ILMN
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.